AbolerIS Pharma to raise €27 millione from Caixa, Bioventures, SFPIM, Wallonie Entreprendre, Sambrinvest, Sudinvest, Newton and Turenne Biotech Health services Pharma Investments 12 September 2023 Share:
Round value (USD): 29.46m Round investors: Caixa Capital Risc Newton Biocapital Sambrinvest Turenne Capital Partenaires InvestSud Sound Bioventures SFPIM Wallonie Entreprendre Company: AbolerIS Pharma Industry: Biotech Health services Pharma
Aqemia closed a €30m extension to its Series A led by Wendel Growth, joined by Eurazeo, Bpifrance and Elaia AI (big data) Biotech Health services Pharma Investments 16 January 2024
Enyo Pharma raised €39M series C with OrbiMed, Morningside ventures, Bpifrance Biotech Health services Manufacturing Pharma Investments 24 December 2023
Antabio raised €25m in Series B led by AMR Action Fund, joined by the EIC Fund, BNP Paribas, Relyens Innovation Santé/Turenne Capital, IRDI Biotech Health services Investments 03 December 2023
Eligo Bioscience in a $30 million Series B funding round, led by Sanofi Ventures, joined by Bpifrance, Khosla Ventures and Seventure Partners Biotech Health services Investments 02 December 2023